NEW YORK (GenomeWeb) – Synlab Pharma said today that it has signed a collaboration agreement with Biotype to offer a Europe-wide clinical trial service for microsatellite instability and DNA polymerase epsilon/polymerase delta 1 mutation detection using Biotype's Modaplex technology.